These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
496 related items for PubMed ID: 32172616
1. Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics. Belisário AR, Carneiro-Proietti AB, Sabino EC, Araújo A, Loureiro P, Máximo C, Flor-Park MV, Rodrigues DDOW, Ozahata MC, McClure C, Mota RA, Gomes Moura IC, Custer B, Kelly S, Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component Brazil. Hemoglobin; 2020 Jan; 44(1):1-9. PubMed ID: 32172616 [Abstract] [Full Text] [Related]
11. Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype. Daniel Y, Hill K, Inusa B, Thein SL, Howard J. Hemoglobin; 2011 Jan; 35(4):406-10. PubMed ID: 21797706 [Abstract] [Full Text] [Related]
16. Molecular Characterization of β- and α-Globin Gene Mutations in Individuals with Borderline Hb A2 Levels. Satthakarn S, Panyasai S, Pornprasert S. Hemoglobin; 2020 Sep; 44(5):349-353. PubMed ID: 33023363 [Abstract] [Full Text] [Related]
17. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study. Kolliopoulou A, Siamoglou S, John A, Sgourou A, Kourakli A, Symeonidis A, Vlachaki E, Chalkia P, Theodoridou S, Ali BR, Katsila T, Patrinos GP, Papachatzopoulou A. Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620 [Abstract] [Full Text] [Related]